首页> 外文OA文献 >SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer

【2h】

SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer

机译：蓝宝石：在结直肠癌患者六周期后，随机期II研究六周期后六个循环后六周期的oxaliplatin

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Y. Munemoto; M. Nakamura; M. Takahashi; M. Kotaka; H. Kuroda; T. Kato; N. Minagawa; S. Noura; M. Fukunaga; H. Kuramochi; T. Touyama; T. Takahashi; K. Miwa; H. Satake; S. Kurosawa; T. Miura; H. Mishima; J. Sakamoto; K. Oba; N. Nagata;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer [J] . Munemoto Y., Nakamura M., Takahashi M., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2019,第期

机译：蓝宝石：在结直肠癌患者六周期后，随机期II研究计划的停止或连续治疗oxaliplatin后六个循环术后胰腺炎
2. mFOLFOX6 Plus Panitumumab Versus 5-FU/LV Plus Panitumumab After Six Cycles of Frontline mFOLFOX6 Plus Panitumumab: A Randomized Phase II Study of Patients With Unresectable or Advanced/Recurrent, RAS Wild-type Colorectal Carcinoma (SAPPHIRE)-Study Design and Rationale [J] . Nagata Naoki, Mishima Hideyuki, Kurosawa Shuichi, Clinical colorectal cancer . 2017,第2期

机译：MfolfoX6加上Panitumumab与5-Fu / LV加上悬浮在六个循环的前线Mfolfox6加上Panitumumab：一种随机期II研究，对患者进行不可切除或先进/复发，Ras野生型结肠直肠癌（蓝宝石） - 学习设计和理论
3. Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer [J] . Dimitrios Pectasides, Vasilios Karavasilis, George Papaxoinis, BMC Cancer . 2015,第1期

机译：Ⅲ期随机临床试验比较了卡培他滨和奥沙利铂（CAPOX）联合5-氟尿嘧啶，亚叶酸和奥沙利铂（改良的FOLFOX6）联合治疗高危II期或III期大肠癌患者的辅助治疗
4. Telenursing in colorectal cancer patient follow-up and treatment assessment: A mixed methods evaluation study [C] . Dias Maria Jose, Fragoso Maria, Lara-Santos Lucio, IEEE International symposium on computer-based medical systems . 2013

机译：远程护理在大肠癌患者随访和治疗评估中的作用：混合方法评估研究
5. Treatment discontinuation among breast, colorectal, and prostate cancer patients in Alabama [D] . Melhado, Trisha V. 2009

机译：在阿拉巴马州的乳腺癌，结肠直肠癌和前列腺癌患者中终止治疗
6. Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer [O] . Dimitrios Pectasides, Vasilios Karavasilis, George Papaxoinis, 2015

机译：III期临床试验比较卡培他滨与奥沙利铂（CAPOX）组合与5-氟尿嘧啶亚叶酸和奥沙利铂（改良的FOLFOX6）组合作为辅助治疗手术后高危II期或III期结直肠癌患者的临床试验
7. mFOLFOX6 Plus Panitumumab Versus 5-FU/LV Plus Panitumumab After Six Cycles of Frontline mFOLFOX6 Plus Panitumumab: A Randomized Phase II Study of Patients With Unresectable or Advanced/Recurrent, RAS Wild-type Colorectal Carcinoma (SAPPHIRE)—Study Design and Rationale [O] . Naoki Nagata, Hideyuki Mishima, Shuichi Kurosawa, 2017

机译：MfolfoX6加上Panitumumab与5-Fu / LV加上悬浮在六个循环的前线Mfolfox6加上Panitumumab：一种随机期II研究，对患者进行不可切除或先进/复发，Ras野生型结肠直肠癌（蓝宝石） - 学习设计和理论

SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer

著录项

相似文献

相关主题

期刊订阅